GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

CXW · Sep 30, 2017

CoreCivic, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001564590-17-022843Reit
Operating-cash-flow growth23thOwn-history percentile · N=13
Evidence method

Yoy · gp.fundamentals.operating_cash_flow

-7.41% · OPTIONAL · VALID

Debt55thOwn-history percentile · N=11
Evidence method

Level · gp.fundamentals.gross_debt

$1.4B · CORE · VALID

Net-income growth8thOwn-history percentile · N=13
Evidence method

Yoy · gp.fundamentals.net_income

-25.59% · CORE · VALID

Cash and equivalents24thOwn-history percentile · N=17
Evidence method

Level · gp.fundamentals.cash

$42.7M · CORE · VALID

Operating-income growth0thOwn-history percentile · N=13
Evidence method

Yoy · gp.fundamentals.operating_income

-17.77% · OPTIONAL · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History49 statesSelf-history eligible
Period transition

What moved in the state?

Cash Generation Decreased
Previous
-1.85%
Current
-7.41%
Delta
-5.55%
Debt Increased
Previous
$1.4B
Current
$1.4B
Delta
$4.0M
Earnings Growth Decreased
Previous
-21.03%
Current
-25.59%
Delta
-4.56%
Liquidity Decreased
Previous
$46.6M
Current
$42.7M
Delta
-$3.8M
Profitability Decreased
Previous
-15.42%
Current
-17.77%
Delta
-2.35%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.